A milestone for innovation in sterile processing
In September 2022, STEAMVision® received a $254,718 National Science Foundation SBIR award. This wasn't just funding; it was competitive, peer-reviewed federal validation at the highest level, confirming the critical problem STEAMVision® addresses and its national significance. Join us as we explore the impact of this prestigious recognition.
Federally validated innovation
The $254,718 NSF SBIR award signals one clear message: STEAMVision® is federally validated innovation, not a speculative idea. It instills confidence that the problem is real, the solution rigorously reviewed, and the platform meets national standards for technical merit and commercial potential. This award represents discipline, credibility, and seriousness, reducing perceived risk for hospital leaders and investors alike. It tells them: "This technology was strong enough to earn competitive federal backing."
From concept to prototype: tangible results
The NSF SBIR award propelled STEAMVision® from concept to a validated prototype. This grant funded the development of a functional mixed-reality MVP, structured workflow scenario design aligned with SPD processes, and technical feasibility validation within a healthcare training environment, including early-stage user testing. Most importantly, it proved three key things: immersive reinforcement in sterile processing is technically viable; the problem is nationally relevant; and hospitals are receptive to modernizing SPD training infrastructure. This acceleration laid the groundwork for pilot engagements across five VA health systems.
Enhancing patient safety and operations
The NSF SBIR award validated STEAMVision® with funding, structure, and technical proof. Development is now focused on scale, not experimentation.
STEAMVision® reduces variability before it reaches the operating room while enabling consistent training and faster onboarding.
Federal validation lowers adoption risk and accelerates impact across healthcare.